A history of drug development in four acts

•The future of pharmaceutical discovery is unclear in light of unique trends in marketing and R&D allocations.•Slowing investment in early-stage discovery raises concerns about pipeline sustainability.•Decreasing NIH funding threatens the future of academia as a source of innovation.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug discovery today 2015-10, Vol.20 (10), p.1163-1168
Hauptverfasser:	Kinch, Michael S., Hoyer, Denton
Format:	Artikel
Sprache:	eng
Schlagworte:	Drug Approval - history Drug Design Drug Discovery - history Drug Discovery - legislation & jurisprudence History, 20th Century History, 21st Century Humans Legislation, Drug - history United States United States Food and Drug Administration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	•The future of pharmaceutical discovery is unclear in light of unique trends in marketing and R&D allocations.•Slowing investment in early-stage discovery raises concerns about pipeline sustainability.•Decreasing NIH funding threatens the future of academia as a source of innovation.
ISSN:	1359-6446 1878-5832
DOI:	10.1016/j.drudis.2015.04.003